Enorama Pharma AB (ERMA) — Capital Reinvestment Ratio
Latest as of December 2015:
4.15x
Enorama Pharma AB (ERMA) has a Capital Reinvestment Ratio of 4.15x as of December 2015, meaning it reinvests 4% of its operating cash flow (Skr480.00K) in capital expenditures (Skr1.99 Million). See Enorama Pharma AB (ERMA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
4.15x
Capex / Operating Cash Flow
Operating Cash Flow
Skr480.00K
SEK
Capital Expenditures
Skr1.99 Million
SEK
Data as of
Dec 2015
Most recent filing
Enorama Pharma AB Capital Reinvestment Ratio (2014–2015)
This chart tracks Enorama Pharma AB's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Enorama Pharma AB (2014–2015)
Year-by-year Capital Reinvestment Ratio for Enorama Pharma AB from 2014 to 2015. For live market cap and broader valuation context, see ERMA market cap.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 4.15x | Skr480.00K | Skr1.99 Million | ▼ -7.8% |
| 2014 | 4.50x | Skr307.00K | Skr1.38 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow